doctor

Lakecia Gunter - Chief Technology Officer at Microsoft Global Partner Solutions

Lakecia Gunter - Chief Technology Officer at Microsoft Global Partner Solutions

A really fun episode with Lakecia Gunter.  Ms. Gunter serves as the Chief Technology Officer for the Global Partner Solutions Team at Microsoft Corporation. Prior to this role, she also held positions at Microsoft as Vice President and General Manager of the Device Partner Solution Sales Group and Vice President and General Manager of IoT Global and Strategic Engagement. Before joining Microsoft, Ms. Gunter served as Vice President of the Programmable Solutions Group and General Manager of Ecosystem Development and Operations at Intel Corporation. While at Intel, she served in several leadership roles, including Chief of Staff and Technical Assistant to the CEO. Ms. Gunter earned her bachelor’s degree in computer engineering from the University of South Florida and her master’s degree in electrical engineering from the Georgia Institute of Technology.   We talked on a wide variety of topics, got some great insights and advice, and most importantly we became members of Team Lakecia!

Dr. Melina Kibbe - Dean of UVA Medicine, Vascular Surgery Clinician & Researcher

Dr. Melina Kibbe - Dean of UVA Medicine, Vascular Surgery Clinician & Researcher

Dr. Melina Kibbe, the Dean of the University of Virginia’s School of Medicine, is our latest guest for the podcast. She is an active, practicing vascular surgeon who has maintained an independently funded basic science/translational research laboratory since 2003. Her clinical practice is focused on the care of patients with vascular disease. As a surgeon-scientist, she has been performing independent research and mentoring trainees in the conduct of hypothesis-driven research. To date, she has mentored 41 postdoctoral fellows, 9 graduate students, 13 medical students, and 21 undergraduate students in research. She also has had significant experience with clinical research and clinical trials, having served as national PI or site PI of gene-and cell-based therapies for critical limb ischemia and peripheral artery disease.